Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Unfortunately, science rarely sticks to a neat script
Neurologically, preclinical studies have documented BPC-157 modulation of dopaminergic and serotonergic systems, enhancement of growth hormone receptor expression, and neuroprotective effects against excitotoxicity
A six-month, double-blind, multicenter experiment using oral L-Lysine monohydrochloride showed that the lysine treatment group averaged 2.4 times fewer HSV outbreaks, with significantly diminished symptoms and shorter healing times (during the research period) than the placebo group
The dual agonist activitytargeting both GIP and GLP-1 receptorsis hypothesized to provide benefits beyond single-receptor agonists
It tells us almost nothing
Learn more about the proven, quantitative results and view the full clinical studies here
